skip to main content

145 King Street West, Suite 2200 | Toronto, Ontario | M5H 4G2 | 416 362 3711

News & Events

BIG DEAL: Aura Health Closes Flagship German Acquisition of 80% of Pharmadrug GmbH

May 17, 2019

Logo - Aura HealthAura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) closed its previously announced (May 8, 2019) acquisition of an 80% equity interest in Pharmadrug Production GmbH (“Pharmadrug”) for total consideration of €5.0 million. Pharmadrug is a cash flow positive German pharmaceutical distribution company with over 20 years of operating history and a Schedule I European Union narcotics license allowing for the distribution of medical cannabis to pharmacies in Germany and throughout the Eurozone as markets become legalized. Pharmadrug has supply agreements in place with Bedrocan International B.V., Canadian Licensed Producers, and is currently supplying medical cannabis to pharmacies in Germany. Minden Gross LLP acted for Aura in the purchase of Pharmadrug with a team led by  Andrew Elbaz (Partner, Securities & Capital Markets), David Judson (Partner, Securities & Capital Markets), and Alex Katznelson (Associate, Securities & Capital Markets).

Profile photo: Andrew Elbaz - Securities and Capital Markets LawyerProfile photo: David Judson, Business Law LawyerProfile photo: Alexander Katznelson, Business Law Lawyer

Our People

Resources

More +

© 2017 Minden Gross LLP  All rights reserved

Legal Marketing | Cubicle Fugitive